Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Prostaglandin E1 measurement |
Has measured component (attribute) |
False |
Alprostadil |
Inferred relationship |
Some |
|
Prostaglandin E1 measurement |
Component |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil |
Is a |
False |
Alprostadil |
Inferred relationship |
Some |
|
Prostaglandin E>1< |
Is a |
False |
Alprostadil |
Inferred relationship |
Some |
|
Prostaglandin E>1< preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Dinoprostone 10mg suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Dinoprostone 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
dinoprostone 1 mg/mL, ampoule de 0,75 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
dinoprostone 10 mg/mL, ampoule de 0,5 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
dinoprostone 10 mg/mL, ampoule de 0,5 mL de concentré avec diluant pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Dinoprostone 400 microgram/mL vaginal gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Dinoprostone 3 mg vaginal tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Product containing gemeprost (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Gemeprost 1 mg vaginal pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Product containing dinoprostone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Product containing dinoprostone in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Dinoprostone-containing product in vaginal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Product containing dinoprostone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Dinoprostone 10mg insert |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Product containing alprostadil in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 40.0mcg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil 500micrograms pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil 20.2mcg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil 1000micrograms pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil 500mcg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 5micrograms powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil adverse reaction |
Causative agent (attribute) |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing alprostadil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
alprostadil 40micrograms powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 40micrograms powder and solvent for injection solution cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 10micrograms powder and solvent for injection solution cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 20micrograms injection cartridge starter pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 500 microgrammes/mL, ampoule de 1 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 10micrograms injection cartridge starter pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil 10.16mcg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 40micrograms injection cartridge starter pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Allergy to alprostadil (finding) |
Causative agent (attribute) |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil 125micrograms pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil 250micrograms pellet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil 20micrograms injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 20micrograms powder and solvent for injection solution cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 10micrograms powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil [erectile dysfunction] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 20micrograms powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil 10micrograms injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil 500mcg suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil 250mcg suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil 125mcg suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil 1000mcg suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil 5mcg/mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 20micrograms cartridge syringe injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
alprostadil 10micrograms cartridge syringe injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Product containing alprostadil in genitourinary dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Allergy to alprostadil (finding) |
Causative agent (attribute) |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 40micrograms powder for conventional release solution for injection cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil 125 microgram urethral stick |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil 250 microgram urethral stick |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Product containing precisely alprostadil 500 microgram/1 each conventional release urethral stick (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Product containing precisely alprostadil 1 milligram/1 each conventional release urethral stick (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alprostadil |
Inferred relationship |
Some |
|
Alprostadil-containing product in urethral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 10 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 10 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 10 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 10 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 20 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 20 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 20 microgram powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 20 microgram powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 40 microgram powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 40 microgram powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 5 microgram powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 5 microgram powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 500 microgram/1 milliliter conventional release solution for infusion ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 500 microgram/1 milliliter conventional release solution for infusion ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing only alprostadil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing only alprostadil in urethral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 500 microgram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 500 microgram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 1 milligram/1 each conventional release urethral stick (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 1 milligram/1 each conventional release urethral stick (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 250 microgram urethral stick |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 250 microgram urethral stick |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 500 microgram/1 each conventional release urethral stick (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 500 microgram/1 each conventional release urethral stick (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 125 microgram urethral stick |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 125 microgram urethral stick |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 20 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 20 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 10 microgram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 10 microgram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 500 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 500 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 500 microgram/mL solution for infusion and/or injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil 500 microgram/mL solution for infusion and/or injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 3 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Product containing precisely alprostadil 3 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |
Alprostadil only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alprostadil |
Inferred relationship |
Some |
1 |